VP of Research Products at bit.bio Dr Farah Patell-Socha is featured in the latest issue of HealthTechWorld.
The piece looks at neurodegenerative diseases including Huntington’s, Parkinson’s and Alzheimer’s disease.
Dr Patell-Socha discusses how consistent cell models can help accelerate research and drug development for these diseases and bit.bio's recently launched product ioGlutamatergic Neurons HTT50CAG/WT - a disease model for Huntington's.
Read the full article here.